These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

595 related articles for article (PubMed ID: 33373432)

  • 1. The Gut Microbial Endocrine Organ in Type 2 Diabetes.
    Massey W; Brown JM
    Endocrinology; 2021 Feb; 162(2):. PubMed ID: 33373432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolites Linking the Gut Microbiome with Risk for Type 2 Diabetes.
    Zhu T; Goodarzi MO
    Curr Nutr Rep; 2020 Jun; 9(2):83-93. PubMed ID: 32157661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding connections and roles of gut microbiome in cardiovascular diseases.
    Rajendiran E; Ramadass B; Ramprasath V
    Can J Microbiol; 2021 Feb; 67(2):101-111. PubMed ID: 33079568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiota-derived metabolites as key actors in type 2 diabetes mellitus.
    Du L; Li Q; Yi H; Kuang T; Tang Y; Fan G
    Biomed Pharmacother; 2022 May; 149():112839. PubMed ID: 35325852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the gut microbiota and its metabolites for type 2 diabetes mellitus.
    Wu J; Yang K; Fan H; Wei M; Xiong Q
    Front Endocrinol (Lausanne); 2023; 14():1114424. PubMed ID: 37229456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut Microbiota and Cardiovascular Disease.
    Witkowski M; Weeks TL; Hazen SL
    Circ Res; 2020 Jul; 127(4):553-570. PubMed ID: 32762536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Relationship between the Gut Microbiome and Metformin as a Key for Treating Type 2 Diabetes Mellitus.
    Lee CB; Chae SU; Jo SJ; Jerng UM; Bae SK
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiota-derived metabolites as central regulators in metabolic disorders.
    Agus A; Clément K; Sokol H
    Gut; 2021 Jun; 70(6):1174-1182. PubMed ID: 33272977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut Microbial Metabolites of Aromatic Amino Acids as Signals in Host-Microbe Interplay.
    Liu Y; Hou Y; Wang G; Zheng X; Hao H
    Trends Endocrinol Metab; 2020 Nov; 31(11):818-834. PubMed ID: 32284282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Micronutrients impact the gut microbiota and blood glucose.
    Barra NG; Anhê FF; Cavallari JF; Singh AM; Chan DY; Schertzer JD
    J Endocrinol; 2021 Jul; 250(2):R1-R21. PubMed ID: 34165440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Gut Microbiota on Onset and Progression of Microvascular Complications of Type 2 Diabetes (T2DM).
    Tanase DM; Gosav EM; Neculae E; Costea CF; Ciocoiu M; Hurjui LL; Tarniceriu CC; Maranduca MA; Lacatusu CM; Floria M; Serban IL
    Nutrients; 2020 Dec; 12(12):. PubMed ID: 33276482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The contribution of gut bacterial metabolites in the human immune signaling pathway of non-communicable diseases.
    Hosseinkhani F; Heinken A; Thiele I; Lindenburg PW; Harms AC; Hankemeier T
    Gut Microbes; 2021; 13(1):1-22. PubMed ID: 33590776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postprandial gut microbiota-driven choline metabolism links dietary cues to adipose tissue dysfunction.
    Schugar RC; Willard B; Wang Z; Brown JM
    Adipocyte; 2018 Jan; 7(1):49-56. PubMed ID: 29172946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary Patterns Affect the Gut Microbiome-The Link to Risk of Cardiometabolic Diseases.
    Tindall AM; Petersen KS; Kris-Etherton PM
    J Nutr; 2018 Sep; 148(9):1402-1407. PubMed ID: 30184227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Dietary Fiber on Gut Microbiota in Host Health and Disease.
    Makki K; Deehan EC; Walter J; Bäckhed F
    Cell Host Microbe; 2018 Jun; 23(6):705-715. PubMed ID: 29902436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The gut microbial endocrine organ: bacterially derived signals driving cardiometabolic diseases.
    Brown JM; Hazen SL
    Annu Rev Med; 2015; 66():343-59. PubMed ID: 25587655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbial metabolites as modulators of host physiology.
    Joyce SA; Clarke DJ
    Adv Microb Physiol; 2024; 84():83-133. PubMed ID: 38821635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiome and metabolites, the future direction of diagnosis and treatment of atherosclerosis?
    Cao H; Zhu Y; Hu G; Zhang Q; Zheng L
    Pharmacol Res; 2023 Jan; 187():106586. PubMed ID: 36460280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus.
    Kootte RS; Vrieze A; Holleman F; Dallinga-Thie GM; Zoetendal EG; de Vos WM; Groen AK; Hoekstra JB; Stroes ES; Nieuwdorp M
    Diabetes Obes Metab; 2012 Feb; 14(2):112-20. PubMed ID: 21812894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Gut Microbiome and Microbial Metabolites in Alleviating Insulin Resistance After Bariatric Surgery.
    Wang M; Li L; Chen Y; Lian G; Wang J; Zhang J; Shan K; Shang L; Tian F; Jing C
    Obes Surg; 2021 Jan; 31(1):327-336. PubMed ID: 32974816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.